Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Mr. Michael KavanaghSenior Director, Head of Strategic Engagement & Oncology Marketing and Non-Independent Director | -526,00 | 142,55k | Verkauf | 271,00 | 0,00 | -100,00% |
| 2026-04-01 | Dr. Judith V. KlimovskyExec. VP & Chief Development Officer | 4,74k | 1,30M | Derivative Exercise and Retained Stock | 273,16 | 15,56k | 43,86% |
| 2026-04-01 | Dr. Tahamtan AhmadiExec. VP, Chief Medical Officer & Head of Experimental Medicines | 5,19k | 1,42M | Derivative Exercise and Retained Stock | 273,16 | 10,05k | 106,66% |
| 2026-04-01 | Mr. Anthony PaganoExec. VP & CFO | 4,21k | 1,15M | Derivative Exercise and Retained Stock | 273,16 | 10,31k | 68,89% |
| 2026-04-01 | Dr. Jan G.J. van de WinkelCo-Founder, President & CEO | 439,00 | 119,92k | Derivative Exercise and Retained Stock | 273,16 | 659,94k | 0,07% |
| 2026-03-02 | Dr. Jan G.J. van de WinkelCo-Founder, President & CEO | 567,00 | 0,00 | Derivative Exercise and Retained Stock | - | 659,50k | 0,09% |
| 2026-03-02 | Mr. Anthony PaganoExec. VP & CFO | 200,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,11k | 3,39% |
| 2026-03-02 | Mr. Martin SchultzSenior Director, Head of Development Business Partnership & Strategy and Director | 197,00 | 0,00 | Derivative Exercise and Retained Stock | - | 865,00 | 29,49% |
| 2026-03-02 | Dr. Mijke ZachariasseVP, Head of Antibody Research Materials & Director | 64,00 | 0,00 | Derivative Exercise and Retained Stock | - | 851,00 | 8,13% |
| 2026-03-02 | Mr. Michael KavanaghSenior Director, Head of Strategic Engagement & Oncology Marketing and Non-Independent Director | 305,00 | 0,00 | Derivative Exercise and Retained Stock | - | 526,00 | 138,01% |
| 2026-02-19 | Mr. Anthony PaganoExec. VP & CFO | -1,10k | 313,50k | Verkauf | 285,00 | 5,91k | -15,70% |
| 2025-12-01 | Dr. Anders Gersel PedersenNon-Independent Director | 189,00 | 60,10 | Derivative Exercise and Retained Stock | 0,32 | 7,71k | 2,51% |
| 2025-12-01 | Ms. Elizabeth G. O'FarrellIndependent Director | 189,00 | 60,10 | Derivative Exercise and Retained Stock | 0,32 | 1,89k | 11,14% |
| 2025-12-01 | Ms. Deirdre P. ConnellyIndependent Chairman of the Board | 378,00 | 120,19 | Derivative Exercise and Retained Stock | 0,32 | 6,58k | 6,09% |
| 2025-12-01 | Mr. Rolf Karl-Heinz HoffmannIndependent Director | 189,00 | 60,10 | Derivative Exercise and Retained Stock | 0,32 | 3,78k | 5,26% |
| 2025-12-01 | Ms. Pernille ErenbjergIndependent Deputy Chairman | 283,00 | 89,98 | Derivative Exercise and Retained Stock | 0,32 | 5,47k | 5,46% |
| 2025-12-01 | Dr. Paolo PaolettiIndependent Director | 189,00 | 60,10 | Derivative Exercise and Retained Stock | 0,32 | 2,51k | 8,16% |
| 2025-12-01 | Mr. Martin SchultzSenior Director, Head of Development Business Partnership & Strategy and Director | 189,00 | 60,10 | Derivative Exercise and Retained Stock | 0,32 | 400,00 | 89,57% |
| 2025-12-01 | Dr. Mijke ZachariasseVP, Head of Antibody Research Materials & Director | 189,00 | 60,10 | Derivative Exercise and Retained Stock | 0,32 | 690,00 | 37,72% |
| 2025-11-19 | Mr. Martin SchultzSenior Director, Head of Development Business Partnership & Strategy and Director | -175,00 | 52,99k | Verkauf | 302,78 | 211,00 | -45,34% |
| 2025-09-09 | Dr. Jan G.J. van de WinkelCo-Founder, President & CEO | 23,27k | 3,75M | Derivative Exercise and Retained Stock | 160,99 | 658,93k | 3,66% |
| 2025-06-17 | Dr. Mijke ZachariasseVP, Head of Antibody Research Materials & Director | -250,00 | 57,34k | Verkauf | 229,37 | 501,00 | -33,29% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
